Long-term association of routine blood count (Coulter) variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I)

International Journal of Epidemiology

Volumn 39, Issue 1, 2010, Pages 256-265

  Pizzi, Costanza ^a   de Stavola, Bianca L ^a   Meade, Tom W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Coronary heart disease; Coulter; Packed cell volume; Proportional hazards model

Indexed keywords

HEMOGLOBIN; THROMBIN;

BLOOD; CARDIOVASCULAR DISEASE; HEMATOLOGY; HEMOGLOBIN; MORTALITY; RISK FACTOR;

ADULT; ARTICLE; BLOOD CELL COUNT; CORONARY RISK; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; THROMBOCYTE COUNT; ADOLESCENT; AGED; BLOOD; CORONARY ARTERY DISEASE; HEALTH BEHAVIOR; HEMATOCRIT; MIDDLE AGED; MORPHOMETRICS; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; BODY WEIGHTS AND MEASURES; CORONARY DISEASE; ERYTHROCYTE COUNT; FEMALE; HEALTH BEHAVIOR; HEMATOCRIT; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77952307497     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp245     Document Type: Article

References (23)

1. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic impor tance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985;254:1932-37.
2. Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-56.
3. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1993;125: 855-63.
4. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996;16:499-503.
5. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54:316-22.
6. Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 2005;15: 266-71.
7. Rana JS, Boekholdt SM, Ridker PM et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med 2007;262: 678-89.
8. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-17.
9. Meade TW, Cooper JA, Miller GJ. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD). Thromb Haemost 1997;78:926-29.
10. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease the Framingham study: a 34-year follow-up. Am Heart J 1994; 127:674-82.
11. Brown DW, Giles WH, Croft JB. Hematocrit and the risk of coronary heart disease mortality. Am Heart J 2001;142: 657-63.
12. Horne MK 3rd, Cullinane AM, Merryman PK, Hoddeson EK. The effect of red blood cells on thrombin generation. Br J Haematol 2006;133:403-8.
13. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2:533-37.
14. De Stavola BL, Meade TW. Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). J Thromb Haemost 2007;5:461-71.
15. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford: Oxford University Press, 1993.
16. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964-74.
17. Office for National Statistics. Living in Britain: Results from the 2000/01 General Household Survey. London: The Stationary Office, 2001.
18. Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549-54.
19. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338: 1409-11.
20. Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? Br Med J 1999; 319:1562-65.
21. Wald NJ, Morris JK, Rish S. The efficacy of combining several risk factors as a screening test. J Med Screen 2005; 12:197-201.
22. Bradlow BA. Liberation of material with platelet-like coagulant properties from intact red cells and particularly from reticulocytes. Br J Haematol 1961;7:476-95.
23. Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 1999;81: 400-6.